January 22, 2025
admin
(20 second reading) Neuland Laboratories Ltd announced that its board of directors approved capital expenditures totalling Rs.342 crore for capacity expansion at its facilities in Telangana.
At unit 1 in Bonthapally, the company plans to increase its peptide synthesiser capacity from 0.5 KL to 6.37 KL. The expansion is expected to be completed by FY27.
The project will be financed through a combination of borrowings and internal accruals and aims to support the development and commercial production of peptides for the generic drug substances (GDS) and custom manufacturing solutions (CMS) business segments.
